Pharmacokinetic study of HS061, a new human insulin, in non-diabetic rat using ultra performance liquid chromatography–tandem mass spectrometry
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 967, 50-56
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Current practices in the management of diabetic nephropathyJournal of the Royal College of Physicians of Edinburgh, 2013
- Potential Roles ofStevia rebaudianaBertoni in Abrogating Insulin Resistance and Diabetes: A ReviewEvidence-Based Complementary and Alternative Medicine, 2013
- Glucagon-like peptide-1 analogues: An overviewIndian Journal of Endocrinology and Metabolism, 2013
- Biomarkers in Diabetic Retinopathy and the Therapeutic ImplicationsMediators of Inflammation, 2013
- How long should a long acting insulin analogue be?Diabetes Research and Clinical Practice, 2012
- Insulin detemir enhances proglucagon gene expression in the intestinal L cells via stimulating β-catenin and CREB activitiesAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Moving towards efficient therapies in type 1 diabetes: To combine or not to combine?Autoimmunity Reviews, 2007
- On-line SPE–RP-LC for the determination of insulin derivatives in biological matricesJournal of Pharmaceutical and Biomedical Analysis, 2003
- A Mass Spectrometric Method for Quantitation of Intact Insulin in Blood SamplesJournal of Analytical Toxicology, 2001
- Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to ImmunoassayJournal of Biological Chemistry, 1997